The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways

Carmen del Río,Carmen Navarrete,Juan A. Collado,M. Luz Bellido,María Gómez-Cañas,M. Ruth Pazos,Javier Fernández-Ruiz,Federica Pollastro,Giovanni Appendino,Marco A. Calzado,Irene Cantarero,Eduardo Muñoz

The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways

2016

Carmen del Río
Carmen Navarrete
Juan A. Collado
M. Luz Bellido
María Gómez-Cañas
M. Ruth Pazos
Javier Fernández-Ruiz
Federica Pollastro
Giovanni Appendino
Marco A. Calzado
Irene Cantarero
Eduardo Muñoz

The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways

Keywords:

Regulation of gene expression
Peroxisome
Peroxisome proliferator-activated receptor
Cannabinoid
Cellular differentiation
Cancer research
HEK 293 cells
Signal transduction
Endocrinology
Internal medicine
Bleomycin
Biology
Agonist
Cannabinoid receptor type 2
Inflammation
Fibrosis
Myofibroblast

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations